Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Luxembourg
100%
Neutralizing Antibodies
100%
Companion Animals
100%
Antibody Profile
100%
Variants of Concern
100%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
100%
Quantitative PCR
28%
Cross-species Transmission
28%
Seroprevalence Rate
28%
Surrogate Neutralization Assay
28%
Human Population
14%
Serum Samples
14%
Virus
14%
Titer
14%
Containment
14%
SARS-CoV-2 Infection
14%
Stool Samples
14%
Transmission Risk
14%
Virus Variants
14%
Human-to-human Transmission
14%
Flow Cell
14%
Transmission Events
14%
Swab Samples
14%
Domestic Animals
14%
Leftovers
14%
Rectal Swab
14%
Host Tropism
14%
Anti-SARS-CoV-2 Antibodies
14%
Acquired mutations
14%
Omicron BA.1
14%
SARS-CoV-2 Variants
14%
BA.1
14%
Respiratory Swabs
14%
Variant Replacement
14%
MinION
14%
Recombinant Spike Protein
14%
SARS-CoV-2 Evolution
14%
Transmission Rate
14%
ARTIC
14%
Dog Serum
14%
Veterinary Hospital
14%
Farmed Mink
14%
Multiplexed
14%
Pregenomic RNA (pgRNA)
14%
Animal Serum
14%
First Cohort
14%
Immunology and Microbiology
Neutralizing Antibody
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Cat
55%
Dog
55%
Infectious Disease
22%
Virus
22%
Neutralization
22%
Quantitative Reverse Transcription Polymerase Chain Reaction
22%
Prevalence
22%
Seroprevalence
22%
Infection
22%
Omicron Coronavirus Variant
11%
Titer
11%
Domestic Animal
11%
Neovison vison
11%
Host Tropism
11%
Ribonucleic Acid
11%
Spike Protein
11%
Veterinary Science and Veterinary Medicine
SARS Coronavirus
100%
Cat
62%
Dog
62%
Prevalence
25%
Quantitative Reverse Transcription Polymerase Chain Reaction
25%
Seroprevalence
25%
SARS-CoV-2 Infection
12%
Domestic Animal
12%
Neovison vison
12%
Veterinary Clinic
12%
Infectious Disease
12%